Press releases of year 2007
19/12/2007
Novagali Pharma strengthens its Executive Management by appointing Dr Mourad Amrane to the head of Medical Affairs.
25/06/2007
Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis.
20/06/2007
Novagali Pharma strengthens its Executive Management.
25/05/2007
Novagali Pharma announced orphan drug designation granted by the FDA to Cyclosporine A drug Vekacia® for the treatment of Vernal Keratoconjunctivitis (VKC).
15/05/2007
Novagali Pharma announces the launch of its new fully accessible website developed by Acom Healthcare.
26/04/2007
Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome.
19/04/2007
Novagali Pharma, appints Philippe Garcia as Chief Financial
Officer.
04/04/2007
Novagali Pharma Announces Positive Vekacia® Clinical Results from Pivotal Phase III Trial in Vernal Keratoconjunctivitis.
23/03/2007
Topigen and Novagali enter into strategic collaboration for allergic ocular diseases and allergic rhinitis.